25 Oct 2017 8:00 AM – 26 Oct 2017 3:30 PM Radisson Blu Steinentorstrasse 25 4001 Basel Switzerland

14th November 2017, London
BMA House
Tavistock Square
London-WC1H 9JP

A European perspective to accelerate Advanced Therapies Gathering the World’s Thought Leaders in Advanced Therapies.

28th-29th June, Tallinn, Estonia

This conference will inspire EU healthcare thought leaders to present research findings and share best practices on the use of data at all points of the healthcare value chain.

February 13th, 2017

This webinar will discuss the mounting challenges to Europe's ATMP sector, and offer tangible suggestions as to what needs to be done to ensure the EU maintains its ability to develop needed new therapies and bring them to patients.

March 8th, 2017

This webinar will present an overview of the challenges to drug development from the standpoint of the need for new sources of evidence. It will also include a presentation on what the 'RWE Navigator' is, and what it does with a live demonstration of the web tool.

March 28th, 2017

DIA is excited to convene its 1st BioVenture Day, in a unique format with participation of a very broad set of senior Health Care stakeholders.You will be able to explore whether the current BioVenture paradigm is delivering return for patients, investors, and the Health Care system.

24th November 2016

IMI 1 GetReal closing meeting: ‘Delivering tools for real-world evidence development’

Supported by:

October 6, 2016

WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.

June 29, 2016, Philadelphia Europe and the US are experimenting with ways to develop therapies based on their actual ‘real world’ performance. This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.